Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Revenue (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed Revenue for 2 consecutive years, with $711000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Revenue fell 75.37% to $711000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was $711000.0, a 89.97% decrease, with the full-year FY2024 number at $4.9 million, down 51.32% from a year prior.
  • Revenue was $711000.0 for Q4 2024 at Spruce Biosciences, up from $600000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.1 million in Q3 2023 to a low of $600000.0 in Q3 2024.